Immunohistochemical analyses have revealed that most metastatic melanoma exhibited strong WNT5A staining comparing to benign tumors and a high WNT5A level in metastatic cutaneous melanoma is associated with poor outcome [125]. The gene discussed is WNT5A; the disease is metastatic melanoma.